Results 91 to 100 of about 51,478 (262)
Laboratory‐Acquired Serogroup A Meningococcal Meningitis
Neisseria meningitidis causes fulminant meningitis and sepsis. Worldwide, N. meningitidis serogroup A is responsible for large epidemic outbreaks (e.g., subSaharan Africa) and serogroups B, C, Y and W-135 cause epidemic and endemic disease. Meningococci are usually transmitted from person to person through close contact with contaminated aerosols and ...
Alexander T. Kessler+2 more
openaire +4 more sources
ABSTRACT Background Leptospirosis is a widespread zoonosis caused by bacteria in the genus Leptospira. Basic epidemiological information is crucial to mitigating disease risk but is lacking for leptospirosis; notably, the hosts responsible for maintaining Leptospira remain largely unknown.
Florence Ayral+4 more
wiley +1 more source
Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV)
The utility of wild-type outer membrane vesicle (wtOMV) vaccines against serogroup B (MenB) meningococcal disease has been explored since the 1970s. Public health interventions in Cuba, Norway and New Zealand have demonstrated that these protein-based ...
J. Holst+10 more
semanticscholar +1 more source
BACKGROUND AND OBJECTIVE: Streptococcus pneumoniae is one of the major pathogens responsible for invasive diseases such as pneumonia and meningitis. Epidemiological studies of these microorganisms are necessary to evaluate the effect of pneumococcal ...
S RafieiTabatabaei+3 more
doaj
Dengue Vaccination: A Practical Guide for Clinicians
Dengue is a growing global public health challenge, with rising incidence and case fatality rates fueled by urbanization and climate change. The substantial mortality, morbidity, and economic burden associated with the disease underscore the need for ...
Kay Choong See
doaj +1 more source
Serogroup A meningococcal conjugate vaccines in Africa
Serogroup A meningococcal epidemics have been a recurrent public health problem, especially in resource-poor countries of Africa. Recently, the administration in mass vaccination campaigns of a single dose of the monovalent meningococcal conjugate vaccine, MenAfriVac, to the 1-29 year-old population of sub-Saharan Africa has prevented epidemics of ...
Paul A. Kristiansen+2 more
openaire +2 more sources
A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
Recently approved in Europe and Australia, the multi-component meningococcal B vaccine, 4CMenB (Bexsero®, Novartis Vaccines and Diagnostics), contains three surface-exposed recombinant proteins (fHbp, NadA, and NHBA) and New Zealand strain outer membrane
M. O’Ryan+4 more
semanticscholar +1 more source
Epidemiology of meningococcal disease in the Panamanian pediatric population, 1998-2008
Introduction: Worldwide public health authorities report 500,000 cases of invasive meningococcal disease with 50,000 deaths per year and 10-15% of sequelae in people affected.
Javier Nieto-Guevara+3 more
doaj +1 more source
Genetic Relatedness of Corriparta Serogroup Viruses
Eight viruses of the Corriparta serogroup (Reoviridae: Orbivirus) that were known to be heterogeneous on the basis of serology and polyacrylamide gel electrophoresis were examined by reciprocal RNA-RNA blot hybridization of genomic RNA. Conserved and variant genes were identified by the degree of hybridization between cognate genes of different ...
D. L. Knudson, H. A. Gonzalez
openaire +2 more sources
In the past two decades, Shiga toxin-producing Escherichia coli (STEC) has been responsible for multiple large-scale outbreaks worldwide, affecting thousands of individuals. While surveillance systems in developed countries such as the United States, the
Ali Nemati+11 more
doaj +1 more source